BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 32352717)

  • 1. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
    Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum trefoil factor 3 predicts disease activity in patients with ulcerative colitis.
    Nakov R; Velikova T; Nakov V; Ianiro G; Gerova V; Tankova L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):788-794. PubMed ID: 30720187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-320a Strengthens Intestinal Barrier Function and Follows the Course of Experimental Colitis.
    Cordes F; Brückner M; Lenz P; Veltman K; Glauben R; Siegmund B; Hengst K; Schmidt MA; Cichon C; Bettenworth D
    Inflamm Bowel Dis; 2016 Oct; 22(10):2341-55. PubMed ID: 27607334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
    Mitsialis V; Wall S; Liu P; Ordovas-Montanes J; Parmet T; Vukovic M; Spencer D; Field M; McCourt C; Toothaker J; Bousvaros A; ; ; Shalek AK; Kean L; Horwitz B; Goldsmith J; Tseng G; Snapper SB; Konnikova L
    Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases?
    Kaplan M; Yuksel M; Ates I; Kilic ZM; Kilic H; Kuzu UB; Kayacetin E
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1120-5. PubMed ID: 26642816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures.
    Wang J; Ortiz C; Fontenot L; Xie Y; Ho W; Mattai SA; Shih DQ; Koon HW
    PLoS One; 2020; 15(4):e0231796. PubMed ID: 32287314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease.
    Batra SK; Heier CR; Diaz-Calderon L; Tully CB; Fiorillo AA; van den Anker J; Conklin LS
    Inflamm Bowel Dis; 2020 Sep; 26(10):1597-1606. PubMed ID: 32793975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease.
    Wang H; Zhang S; Yu Q; Yang G; Guo J; Li M; Zeng Z; He Y; Chen B; Chen M
    Medicine (Baltimore); 2016 Feb; 95(5):e2703. PubMed ID: 26844512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Alterations in the Composition of Mucosal Innate Lymphoid Cells in Newly Diagnosed and Established Crohn's Disease and Ulcerative Colitis.
    Forkel M; van Tol S; Höög C; Michaëlsson J; Almer S; Mjösberg J
    J Crohns Colitis; 2019 Jan; 13(1):67-78. PubMed ID: 30496425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease.
    Mohammadi A; Kelly OB; Filice M; Kabakchiev B; Smith MI; Silverberg MS
    J Crohns Colitis; 2018 Apr; 12(5):568-581. PubMed ID: 29420705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease.
    Mak LY; Tong TSM; Cheung KS; Chen LJ; Lui KL; Lau KS; Leung WK
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00138. PubMed ID: 32132451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease.
    Wu F; Guo NJ; Tian H; Marohn M; Gearhart S; Bayless TM; Brant SR; Kwon JH
    Inflamm Bowel Dis; 2011 Jan; 17(1):241-50. PubMed ID: 20812331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating MicroRNA in inflammatory bowel disease.
    Paraskevi A; Theodoropoulos G; Papaconstantinou I; Mantzaris G; Nikiteas N; Gazouli M
    J Crohns Colitis; 2012 Oct; 6(9):900-4. PubMed ID: 22386737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease.
    Pinto-Lopes P; Melo F; Afonso J; Pinto-Lopes R; Rocha C; Melo D; Macedo G; Dias CC; Carneiro F; Magro F;
    Clin Transl Gastroenterol; 2021 Mar; 12(3):e00320. PubMed ID: 33704099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.